z-logo
open-access-imgOpen Access
Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization
Author(s) -
Mason Burley,
Kenn B. Daratha,
Katherine R. Tuttle,
John R. White,
Michael Wilson,
Kelly Armstrong,
Sterling McPherson,
Samuel L. Selinger
Publication year - 2016
Publication title -
journal of managed care and specialty pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.126
H-Index - 63
eISSN - 2376-1032
pISSN - 2376-0540
DOI - 10.18553/jmcp.2016.22.4.381
Subject(s) - medicine , emergency department , medical prescription , medical emergency , health care , emergency medicine , family medicine , medical record , nursing , economics , radiology , economic growth
Manufacturer prescription assistance programs (PAPs) have been developed to provide medications at little or no cost to eligible patients. There are over 200 PAPs available from pharmaceutical companies, and each may have different eligibility requirements and assistance guidelines. A formalized community-based patient prescription coordinator can help patients navigate these programs by reviewing an applicant's financial information and medication requirements to identify which PAPs are most appropriate. Little is known, however, about whether providing such guidance is associated with a reduction in acute care utilization.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom